Press release report
Risks of Decompression Sickness and Venous Thromboembolism during Spaceflight and Patent Foramen Ovale Implications
NASA’s Office of the Chief Health and Medical Officer formed a working group in August 2026 to review the most recent data related to extravehicular activity (EVA) prebreathe testing and decompression sickness (DCS) events, venous thromboembolism (VTE) in-flight occurrences, and patent foramen ovale (PFO) implication as they relate to NASA’s Artemis (lunar and beyond) missions. The recommendations from this working group are built upon and integrate the outcomes of previous working groups hosted by OCHMO.
coverage / Wire report
Get updates, read source context, send useful records, share the story, or support the reporting work from the reading page.
NASA’s Office of the Chief Health and Medical Officer formed a working group in August 2026 to review the most recent data related to extravehicular activity (EVA) prebreathe testing and decompression sickness (DCS) events, venous thromboembolism (VTE) in-flight occurrences, and patent foramen ovale (PFO) implication as they relate to NASA’s Artemis (lunar and beyond) missions. The recommendations from this working group are built upon and integrate the outcomes of previous working groups hosted by OCHMO.
Check the original link, updates, and responses when a detail is contested.
Open topic or search related wording such as records, sources, agencies, dates, and locations.
What happened
According to NASA’s press release item, Risks of Decompression Sickness and Venous Thromboembolism during Spaceflight and Patent Foramen Ovale Implications, NASA’s Office of the Chief Health and Medical Officer formed a working group in August 2026 to review the most recent data related to extravehicular activity (EVA) prebreathe testing and decompression sickness (DCS) events, venous thromboembolism (VTE) in-flight occurrences, and patent foramen ovale (PFO) implication as they relate to NASA’s Artemis (lunar and beyond) missions. The recommendations from this working group are built upon and integrate the outcomes of previous working groups hosted by OCHMO.
Context
The development sits in VINI’s Technology file for readers following technology, science, product policy, markets, infrastructure, and the public consequences of innovation. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The source item is dated 2026-09-22T19:19:45+00:00.
What to watch
Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.
Source
Primary source: Risks of Decompression Sickness and Venous Thromboembolism during Spaceflight and Patent Foramen Ovale Implications via NASA. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.
Keep following
This file can keep developing
vininews.com uses reader tips, public records, right-of-reply requests, corrections, and follow-up reporting to keep important stories current.
Support and subscriptions never buy coverage, placement, suppression, or corrections.
This VINI report keeps the original publisher link available and does not republish third-party article bodies without rights clearance. 1 reference listed.
Source links
- Risks of Decompression Sickness and Venous Thromboembolism during Spaceflight and Patent Foramen Ovale ImplicationsNASA - 2026-09-22T19:19:45+00:00
Reader comments
Moderated discussion
Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.
No approved comments yet.
Substantive, civil comments can be submitted by approved account holders.